THURSDAY, July 17, 2025 (HealthDay News) — For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) […]
The post GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications first appeared on Blackandmed .
